Immunologic Control of Disseminated Aichi Virus Infection in X-Linked Agammaglobulinemia by Transplantation of TcRαβ-Depleted Haploidentical Hematopoietic Cells
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Journal of clinical immunology - 42(2022), 7 vom: 05. Okt., Seite 1401-1404 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bekassy, Zivile [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Letter |
|---|
| Anmerkungen: |
Date Completed 22.11.2022 Date Revised 15.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10875-022-01314-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343095939 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343095939 | ||
| 003 | DE-627 | ||
| 005 | 20231226015633.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10875-022-01314-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1143.xml |
| 035 | |a (DE-627)NLM343095939 | ||
| 035 | |a (NLM)35788939 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bekassy, Zivile |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immunologic Control of Disseminated Aichi Virus Infection in X-Linked Agammaglobulinemia by Transplantation of TcRαβ-Depleted Haploidentical Hematopoietic Cells |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.11.2022 | ||
| 500 | |a Date Revised 15.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Receptors, Antigen, T-Cell, alpha-beta |2 NLM | |
| 700 | 1 | |a Ehinger, Mats |e verfasserin |4 aut | |
| 700 | 1 | |a Pronk, Linda Nyberg |e verfasserin |4 aut | |
| 700 | 1 | |a Pronk, Cornelis Jan |e verfasserin |4 aut | |
| 700 | 0 | |a SMPOT group |e verfasserin |4 aut | |
| 700 | 1 | |a Bekassy, Zivile |e investigator |4 oth | |
| 700 | 1 | |a Ehinger, Mats |e investigator |4 oth | |
| 700 | 1 | |a Pronk, Linda Nyberg |e investigator |4 oth | |
| 700 | 1 | |a Pronk, Cornelis Jan |e investigator |4 oth | |
| 700 | 1 | |a Turkiewicz, Dominik |e investigator |4 oth | |
| 700 | 1 | |a Lindström, Martin |e investigator |4 oth | |
| 700 | 1 | |a Król, Ladislav |e investigator |4 oth | |
| 700 | 1 | |a Brodszki, Nicholas |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical immunology |d 1981 |g 42(2022), 7 vom: 05. Okt., Seite 1401-1404 |w (DE-627)NLM012677426 |x 1573-2592 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2022 |g number:7 |g day:05 |g month:10 |g pages:1401-1404 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10875-022-01314-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2022 |e 7 |b 05 |c 10 |h 1401-1404 | ||